As a high-performing scientist with a passion for innovation in the pharmaceutical industry, I bring a creative edge to the lab bench. With over 5 years of working experience, I've gained valuable insights in both small and corporate firms, spanning from industrial-scale production to strategic planning for startups. This hands-on experience complements my research background, enabling me to translate theory into tangible real-world solutions.

My expertise extends to evaluating technologies, crafting positioning strategies, and conducting market research, contributing to the success of companies like Alibion AG (Switzerland) and Aristoteles Data Analytics (Costa Rica). Additionally, my background includes roles in regulatory affairs and project management at Dow Chemical in Central America, where I led global regulatory planning improvements and managed regulatory affairs for numerous products.

Currently, I'm pursuing a doctorate at ETH Zurich in Drug Formulation & Delivery, specializing in oral delivery of peptides. During my research, I've actively contributed to advancements in the field by developing a 3D-printable biodegradable latex for oral delivery devices. My goal is to further advance in the biotech field, driving innovation and enhancing patient outcomes. 

Passionate about market development and positioning strategy, I'm committed to bringing innovative pharmaceutical/biotech products to market effectively. Open to positions in competitive intelligence, strategy, venture building, venture capital, technology scouting or anything where science and business intersect.